ASPECT
Description:
ASPECT Aspirin Esomeprazole Chemoprevention trial
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Mr. Joseph Rahamim | Plymouth Hospitals NHS Trust | Closed |
| Dr. Richard Ellis | Royal Cornwall Hospitals NHS Trust | Closed |
| Dr. Tawfique Daneshmend | Royal Devon & Exeter NHS Foundation Trust | Closed |
| Dr. Cathryn Edwards | South Devon Healthcare NHS Trust | Closed |
BEST- BARRETT'S
Description:
BEST- BARRETT'S-Oesophagus Screening Trial
Phase: Open
Type: NCRN|
No current active trials.
|
|---|
BILCAP
Description:
BILCAP A randomised clinical trial evaluating adjuvant chemotherapy with capecitabine compared to expectant treatment alone following surgery for biliary tract cancer
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Sarah Pascoe | Plymouth Hospitals NHS Trust | Open |
BOSS
Description:
BOSS -Barrett�s Oesophagus two yearly Surveillance versus no Surveillance: a randomised controlled trial to estimate effectiveness and cost-effectiveness
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Royal Cornwall Hospitals NHS Trust | Open |
ChOPIN
Description:
ChOPIN-Chemoprevention of premalignant intestinal neoplasia (ChOPIN) incorporating inherited predisposition of neoplasia (IPOD) analysis of genomic DNA from AspECT and BOSS clinical trials.(co-adopted study-entry via Oral and Gastrointestinal teams).
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Northern Devon Healthcare NHS Trust | Open-via Gastrointestinal Team |
COG
Description:
COG-Phase III randomised, double-blind, placebo-controlled trial of gefitinib (Iressa�) versus placebo in oesophageal cancer progressing after chemotherapy
Phase: In Setup
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Liz Toy | South Devon Healthcare NHS Trust | Open |
ESPAC -Tplus
Description:
ESPAC -Tplus-Translational Studies
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Mark Napier | Northern Devon Healthcare NHS Trust | Open |
| Dr Sarah Pascoe | Plymouth Hospitals NHS Trust | Open |
| South Devon Healthcare NHS Trust | Open |
ESPAC-3(v2)
Description:
ESPAC-3(v2) Phase III Adjuvant Trial in Pancreatic Cancer Comparing 5FU and D-L-Folinic Acid vs. Gemcitabine
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr. Mark Napier | Northern Devon Healthcare NHS Trust | Closed |
| Dr. Francis Daniel | Plymouth Hospitals NHS Trust | Closed |
| Dr. Elizabeth Toy | Royal Devon & Exeter NHS Foundation Trust | Closed |
| Dr. Elizabeth Toy | South Devon Healthcare NHS Trust | Closed |
ESPAC-4
Description:
ESPAC-4-EUROPEAN STUDY GROUP FOR PANCREATIC CANCER - TRIAL 4. Combination versus single agent chemotherapy in resectable pancreatic cancer
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Mark Napier | Northern Devon Healthcare NHS Trust | Open |
| Dr Sarah Pascoe | Plymouth Hospitals NHS Trust | Open |
OE05
Description:
OE05 A randomised controlled trial comparing standard chemotherapy followed by resection versus ECX chemotherapy followed by resection in patients with resectable adenocarcinoma of the oesophagus
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr. Sarah Pascoe | Plymouth Hospitals NHS Trust | Open |
| Dr. Richard Ellis | Royal Cornwall Hospitals NHS Trust | Open |
| Dr. Elizabeth Toy | Royal Devon & Exeter NHS Foundation Trust | Open |
| Dr. Elizabeth Toy | South Devon Healthcare NHS Trust | Open |
REAL-3
Description:
REAL-3-A randomised open-labelled multicentre trial of the efficacy of epirubicin, oxaliplatin and capecitabine (EOX) with or without panitumumab in previously untreated advanced oesophago-gastric cancer (REAL3)
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Mark Napier | Northern Devon Healthcare NHS Trust | Open |
SOCS Stomach and Oesophageal Cancer Study(SOCS)
Description:
SOCS Stomach and Oesophageal Cancer Study(SOCS)-Establishment of a population-based resource to help identify the genetic and environmental determinants of oesophageal and gastric adenocarcinomas
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Mark Napier | Northern Devon Healthcare NHS Trust | Open |
| Dr. Elizabeth Toy | Royal Devon & Exeter NHS Foundation Trust | Open |
| Dr Liz Toy | South Devon Healthcare NHS Trust | Open |
ST03
Description:
ST03-A Randomised Phase III trial of Peri-operative Chemotherapy with or without Bevacizumab in Operable Adenocarcinoma of the Stomach and Gastro-oesophageal Junction
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Sarah Pascoe | Plymouth Hospitals NHS Trust | Open |
| Royal Cornwall Hospitals NHS Trust | Open |
| Royal Devon & Exeter NHS Foundation Trust | Open |
| Dr Liz Toy | South Devon Healthcare NHS Trust | Open |
Telovac
Description:
TeloVac -A prospective, phase III, controlled, multicentre, randomised clinical trial comparing combination Gemcitabine and Capecitabine therapy with concurrent and sequential chemoimmunotherapy using a telomerase vaccine in locally advanced and metastati
Phase: Open
Type: NCRN|
Contact Person
|
Location
|
Stage
|
|---|
| Dr Mark Napier | Northern Devon Healthcare NHS Trust | Open |
| Dr. Richard Ellis | Royal Cornwall Hospitals NHS Trust | Open |
| Dr. Elizabeth Toy | Royal Devon & Exeter NHS Foundation Trust | Open |
| Dr. Elizabeth Toy | South Devon Healthcare NHS Trust | Open |